Quipt Home Medical Clears Key Antitrust Hurdle in Acquisition

Quipt Home Medical ( (TSE:QIPT) ) has provided an update.

On December 14, 2025, Quipt Home Medical Corp. entered into an arrangement agreement under which 1567208 B.C. Ltd., backed by REM Aggregator, LLC, will acquire all of Quipt’s outstanding common shares for $3.65 per share in cash via a court-approved plan of arrangement under British Columbia corporate law. The company announced that as of 11:59 p.m. on January 22, 2026, the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act expired for the proposed transaction, satisfying a key regulatory condition and moving the deal closer to completion, though it still requires shareholder approval and other customary closing conditions, marking a significant step toward Quipt’s transition to new ownership and potential change in its capital structure.

The most recent analyst rating on (TSE:QIPT) stock is a Hold with a C$5.50 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.

Spark’s Take on TSE:QIPT Stock

According to Spark, TipRanks’ AI Analyst, TSE:QIPT is a Neutral.

The score is driven primarily by strong growth and improving free cash flow, partially offset by persistent unprofitability and a valuation profile tied to losses. Technicals are supportive but overbought signals reduce the near-term outlook.

To see Spark’s full report on TSE:QIPT stock, click here.

More about Quipt Home Medical

Quipt Home Medical Corp. is a British Columbia–based provider in the home medical equipment and services sector, focusing on delivering healthcare products and support to patients in non-hospital settings across its operating markets.

Average Trading Volume: 41,375

Technical Sentiment Signal: Hold

Current Market Cap: C$216.2M

Learn more about QIPT stock on TipRanks’ Stock Analysis page.